Tenure-Track Assistant Professor (RTT) at the University of Bologna since 2025, conducting research in the field of Medical Oncology. His main research interests include neuroendocrine tumors, thoracic neuroendocrine neoplasms—with a particular focus on small cell lung cancer (SCLC)—and clinical research methodology in oncology. His research projects focus on advanced molecular characterization of neuroendocrine neoplasms and the design and conduct of independent clinical trials.
Education
He graduated in Medicine and Surgery in 2013 from the University of Naples Federico II and completed his residency in Medical Oncology in 2019 at the University of Bologna. During the final year of his residency, he completed a research fellowship at the Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute – Harvard Medical School Cancer Center (Boston, USA), where he conducted a research project on predictive biomarkers of response to immunotherapy in lung cancer.
He subsequently earned a PhD in Oncology in 2023 with a research project focused on a multicenter Italian clinical trial investigating the combination of angiogenesis inhibition with chemoimmunotherapy in patients with advanced small cell lung cancer (SCLC). In 2022, he completed a second one-year research fellowship in thoracic oncology at the Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute – Harvard Medical School Cancer Center (Boston, USA). From 2022 to 2025, he served as a fixed-term Assistant Professor (RTD-A) at the Alma Mater Studiorum – University of Bologna.
Scientific Activity
Author of more than 100 peer-reviewed publications in international scientific journals.
Membership in Scientific and Editorial Committees
2020–2023: Member of the Steering Committee, Methods in Clinical Cancer Research Alumni (MCCR Alumni)
2024–present: Member of the Scientific Committee of the Italian Society of Neuroendocrine Tumors (ITANET)
Awards and Honors
2019: SITC 2019 Abstract Travel Award
2020: Federico Calabresi Foundation Award
2021 and 2023: Honorable Mention, AIACE Foundation
2023: Best Abstract Award – Targeted Therapies in Lung Cancer
2024: Beretta Foundation Award
